文献速递神经肿瘤

复发性低级别胶质瘤新型预后特征标识的鉴定

Identification of Novel Prognostic Signature of Recurrent Low-Grade Glioma.
PubMed 文献 · World Neurosurg · 2024-07-26

基于中国胶质瘤基因组图谱数据库的RNA测序数据,对复发性低级别胶质瘤(rLGG)进行生物信息学分析,构建了12基因预后特征将患者分为高风险和低风险亚组,在训练队列和验证队列中均显示良好预测效果;多因素Cox分析识别出4个独立预后因素,其中ZCWPW1为高价值保护因素。

要点

  • 构建12基因预后特征,将rLGG患者分为高风险和低风险亚组。
  • LASSO-Cox回归显示该特征在训练队列和验证队列中均有良好预测效果。
  • 多因素Cox分析识别4个独立预后因素,ZCWPW1为高价值保护因素。

核心结论

  • 该预后模型对rLGG患者总生存期显示稳健预测能力,为rLGG提供新的监测方法。
  • 4个独立预后因素尤其是ZCWPW1可作为rLGG的潜在靶点,为治疗带来新可能。

研究设计与样本

  • 基于中国胶质瘤基因组图谱数据库的rLGG RNA测序数据进行系列生物信息学分析。

主要发现

  • 构建12基因预后特征,将所有rLGG患者分为高风险和低风险亚组。
  • LASSO-Cox回归显示该特征在训练队列和验证队列中均有良好预测效果。
  • 多因素Cox分析识别出4个rLGG独立预后因素,其中ZCWPW1为高价值保护因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The prognosis of patients with recurrent low-grade glioma (rLGG) varies greatly. Some patients can survive >10 years after recurrence, whereas other patients have <1 year of survival. METHODS: To identify the related risk factors affecting the prognosis of patients with rLGG, we performed a series of bioinformatics analyses on RNA sequencing data of rLGG based on the Chinese Glioma Genome Altas database. RESULTS: We constructed a 12-gene prognostic signature, dividing all the patients with rLGG into high- and low-risk subgroups. The result showed an excellent predictive effect in both the training cohort and the validation cohort using LASSO-Cox regression. Moreover, multivariate Cox analysis identified 4 independent prognostic factors of rLGG; among them, ZCWPW1 is identified as a high-value protective factor. CONCLUSIONS: In all, this prognostic model displayed robust predictive capability for the overall survival of patients with rLGG, providing a new monitoring method for rLGG. The 4 independent prognostic factors, especially ZCWPW1, can be potential targets for rLGG, bringing new possibilities for the treatment of patients with rLGG.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Shi S, Liang H, Huang Q, et al. Identification of Novel Prognostic Signature of Recurrent Low-Grade Glioma. World Neurosurg. 2024. PMID: 39069129. doi:10.1016/j.wneu.2024.07.147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。